Oklahoma is fertile ground for bioscience growth, talent and premier facilities:

• The Oklahoma Center for the Advancement of Science and Technology (OCAST) has funded 2,700 projects at more than $285 million, attracting $6.5 billion in private sector and federal dollars for a return on investment of 22:1.
• The University of Oklahoma Health Sciences Center is dedicated to both basic and translational research, with patient-centered care and research ongoing at the Stephenson Cancer Center, the Harold Hamm Diabetes Center and the Dean McGee Eye Institute.
• The University Research Park is part of the University of Oklahoma Health Sciences Center campus located in Oklahoma City, Oklahoma. The complex consists of more than 700,000 square feet of modern biomedical research lab and office space supported by state-of-the-art communications and infrastructure systems.
• The Noble Research Institute is the largest private foundation in the country conducting plant science and agriculture research.
• Oklahoma State University is a leader in agriculture and animal science research.
• In the past year, i2E, Inc. invested over $4.8 million in 10 Oklahoma bioscience or life science companies and $28 million over the past 20 years.

Bioscience in Oklahoma truly is driving innovation that is improving lives and creating jobs! Here is a look at some of our emerging bio companies:

• Selexys Pharmaceuticals was acquired by Novartis Pharmaceuticals. The founders of Selexys remain in Oklahoma and are working on a new company, Tetherex, which is focused on development of antibodies for the treatment of inflammatory and thrombotic diseases. 
• Linear Health Sciences is a medtech startup working on new safety release valve technology for medical tubing. Its Orchid valve will help reduce central lines, provide more efficient IV setups, and decrease risk of dislodgment — saving hospitals money and time by avoiding additional procedures. They are the first to receive a grant from the Global Center for Medical Innovation (GCMI), a comprehensive medical device innovation center.
• Moleculera Labs is a pioneer in infection-induced autoimmune conditions that disrupt neurologic function. The company currently markets a diagnostic test, the Cunningham Panel, which predicts a patient’s likelihood having Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococci (PANDAS).
• Cytovance Biologics, Inc. is a pharmaceutical contract manufacturer producing biologics, therapeutic proteins and antibodies, and was recently acquired in a $206 million deal. The company employs more than 170, and their products are used globally for clinical trials and research.
• Accele BioPharma, a bioscience business accelerator, has four bio companies under management that focus on infectious disease, diabetes, drug-resistant bacterial infections and hearing loss.
• Immuno Mycologics is listed as one of Inc.’s fastest-growing private companies in the nation. IMMY is a diagnostic manufacturing company that has evolved from a company that filled a need in the infectious disease market to an organization with a global focus on saving lives through innovative products.
• The Arthrokinex comprehensive joint health program can reduce or eliminate joint pain from Osteoarthritis utilizing the healing power in a patient’s own blood. 
• Progentec Diagnostics, Inc. has developed an advanced state-of-the-art Lupus flare diagnostic, which has potential to fundamentally change the current treatment paradigm for Lupus.  The company has partnered with the Oklahoma Medical Research Foundation, a Center of Excellence for Lupus in the US and they are striving to accelerate commercialization of the patented diagnostic technology by early 2018.
• Biolytx is a pharmaceutical technology company developing a novel antibiotic peptide for potential use in wound healing and treatment of serious hospital-acquired infections, including those resistant to current antibiotics.  The technology was developed in the University of Oklahoma Health Sciences Center laboratory of Dr. Anne Pereira and licensed from OU.  

Oklahoma is recognized internationally for the strength of our research institutions:

• Hough Ear Institute
• Laureate Institute of Brain Research
• Oklahoma Medical Research Foundation
• Oklahoma State University
• Samuel Roberts Noble Foundation
• University of Oklahoma Health Sciences Center
  • Dean McGee Eye Institute
  • Stephenson Cancer Center
  • Harold Hamm Diabetes Center
• University of Tulsa

Our research institutions demonstrate excellence in select areas of human, plant and animal science, with strong emphasis in:

• Agricultural productivity
• Autoimmune diseases and Immunology
• Biofuels
• Cancer
• Cardiovascular Research
• Glycobiology and Carbohydrates
• Infectious Disease and Microbiology
• Natural Products for Health
• Plant Improvement
• Value-Added Food Product
• Vision Research

Innovative service providers facilitate the growth of Oklahoma biosciences:

• Accele BioPharma
• ARL/DNA Solutions
• Cytovance Biologics
• Emergent Technologies
• EyeCRO
• i2E, Inc.
• Lynn Health Sciences Institute
• OKBio Association
• Oklahoma Center for the Advancement of Science and Technology
• Oklahoma Life Science Fund